Literature DB >> 14759780

Management of adult blunt splenic injuries: comparison between level I and level II trauma centers.

Brian G Harbrecht1, Mazen S Zenati, Juan B Ochoa, Ricard N Townsend, Juan C Puyana, Mark A Wilson, Andrew B Peitzman.   

Abstract

BACKGROUND: The factors important in determining outcome when managing adult blunt splenic injuries continue to be debated. Whether trauma center level designation (Level I versus Level II) affects patient management has not been evaluated. STUDY
DESIGN: We conducted a retrospective analysis of prospectively gathered data from the Pennsylvania Trauma Outcome Study database that collected information from 27 statewide trauma centers (Level I [15], Level II [17]). Adult patients (ages > or = 16 years) with blunt splenic injuries (ICD-9-CM 865) were evaluated. Demographic data, injury data, and trauma center level designation were collected, and patient management, length of stay, and mortality were analyzed.
RESULTS: There were 2,138 adult patients who suffered blunt splenic injuries during the study period (1998-2000). Patients treated at Level II trauma centers (n = 772) had a higher rate of operative treatment (38.2% versus 30.7%) (p < 0.001), but a shorter mean length of stay (10.1 +/- 0.4 versus 12.0 +/- 0.4 days) (p < 0.01) compared with patients in Level I trauma centers (n = 1,366). The rate of failure of nonoperative treatment was lower at Level II trauma centers (13.0% versus 17.6%) (p < 0.05), but the mortality for patients managed nonoperatively was higher (8.4% versus 4.5%) (p < 0.05). Splenorrhaphy was performed more frequently in Level I trauma centers.
CONCLUSIONS: Management differences exist in the treatment of adult blunt splenic injuries between institutions of different trauma center level designation. Multicenter studies should account for this finding in design and implementation.

Entities:  

Mesh:

Year:  2004        PMID: 14759780     DOI: 10.1016/j.jamcollsurg.2003.10.007

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  7 in total

Review 1.  Is non-operative management safe and effective for all splenic blunt trauma? A systematic review.

Authors:  Roberto Cirocchi; Carlo Boselli; Alessia Corsi; Eriberto Farinella; Chiara Listorti; Stefano Trastulli; Claudio Renzi; Jacopo Desiderio; Alberto Santoro; Lucio Cagini; Amilcare Parisi; Adriano Redler; Giuseppe Noya; Abe Fingerhut
Journal:  Crit Care       Date:  2013-09-03       Impact factor: 9.097

2.  Variability in Current Trauma Systems and Outcomes.

Authors:  Adel Elkbuli; Brianna Dowd; Rudy Flores; Dessy Boneva; Mark McKenney
Journal:  J Emerg Trauma Shock       Date:  2020-09-18

3.  Nonoperative Management of Blunt Splenic Trauma: Also Feasible and Safe in Centers with Low Trauma Incidence and in the Presence of Established Risk Factors.

Authors:  Gustav Norrman; Bobby Tingstedt; Mikael Ekelund; Roland Andersson
Journal:  Eur J Trauma Emerg Surg       Date:  2008-12-08       Impact factor: 3.693

4.  Splenic injuries: factors affecting the outcome of non-operative management.

Authors:  A Böyük; M Gümüş; A Önder; M Kapan; I Aliosmanoğlu; F Taşkesen; Z Arıkanoğlu; E Gedik
Journal:  Eur J Trauma Emerg Surg       Date:  2011-10-12       Impact factor: 3.693

5.  Splenic trauma in Scotland: demographics and outcomes.

Authors:  Richard R W Brady; Mark Bandari; Jan J Kerssens; Simon Paterson-Brown; Rowan W Parks
Journal:  World J Surg       Date:  2007-11       Impact factor: 3.352

Review 6.  Literature review of the role of ultrasound, computed tomography, and transcatheter arterial embolization for the treatment of traumatic splenic injuries.

Authors:  Cornelis H van der Vlies; Otto M van Delden; Bastiaan J Punt; Kees J Ponsen; Jim A Reekers; J Carel Goslings
Journal:  Cardiovasc Intervent Radiol       Date:  2010-07-29       Impact factor: 2.740

7.  Non-operative management of blunt splenic injury: is it really so extensively feasible? a critical appraisal of a single-center experience.

Authors:  Pietro Fransvea; Gianluca Costa; Giulia Massa; Barbara Frezza; Paolo Mercantini; Genoveffa BaIducci
Journal:  Pan Afr Med J       Date:  2019-01-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.